NEW YORK, June 28, 2021 /PRNewswire/ — The age-related macular degeneration market will witness USD 4.00 billion growth during 2021-2025, according to the latest market research report by Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the age-related macular degeneration market in optimistic, probable, and pessimistic forecast scenarios.
The age-related macular degeneration market is expected to witness a neutral impact during the forecast period due to the ongoing COVID-19 pandemic. Tecnavio expects the market growth to increase in 2021 as compared to 2020.
Organizations across the globe are gradually flattening their recessionary curve by leveraging technology. Many businesses are going through response, recovery, and renewal phases. Building business resilience and enabling agility will aid organizations to move forward in their journey out of the COVID-19 crisis towards the next normal.
This post-pandemic business planning research will aid clients to:
- Adjust their strategic planning to move ahead once business stability kicks in.
- Build Resilience by making effective resource and investment choices for individual business units, products, and service lines.
- Conceptualize scenario-based planning to mitigate future crisis situations.
Key Considerations for Market Forecast:
- Impact of lockdowns, supply chain disruptions, demand destruction, and change in customer behavior
- Optimistic, probable, and pessimistic scenarios for all markets as the impact of pandemic unfolds
- Pre- as well as post-COVID-19 market estimates
- Quarterly impact analysis and updates on market estimates
Gain instant access to 17,000+ market research reports by using
Technavio’s SUBSCRIPTION platform
Related Reports on Healthcare Include:
Global Ophthalmology Therapeutics Market – Global ophthalmology therapeutics market is segmented by product (retinal disorder therapeutics, glaucoma therapeutics, dry eye disease therapeutics, eye infections and inflammation therapeutics, and other therapeutics) and geography (North America, Europe, Asia, and ROW).
Request a Free Sample Report
Global Fundus Cameras Market – Global fundus cameras market is segmented by product (non-mydriatic fundus cameras, hybrid fundus cameras, and mydriatic fundus cameras) and geography (North America, APAC, Europe, and ROW).
Request a Free Sample Report
Major Three Age-related Macular Degeneration Market Participants:
AbbVie Inc.: The company offers biodegradable implants for the reduction of intraocular pressure (IOP) in patients.
Alkeus Pharmaceuticals Inc.: The company offers ALK-001 an oral drug to treat age-related macular degeneration.
Amgen Inc.: The company offers age-related macular degeneration under the brand name ABP 938.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Get a report snapshot here to get a detailed market share analysis of market participants during COVID-19 lockdown:
Age-related Macular Degeneration Market 2021-2025: Segmentation
Age-related macular degeneration market is segmented as below:
- Wet AMD
- Dry AMD
- North America
The age-related macular degeneration market is driven by the high prevalence of AMD. In addition, a strong pipeline and expected approvals for drugs are likely to trigger the age-related macular degeneration market toward witnessing a CAGR of almost 6% during the forecast period.
Gain more insights about the global trends impacting the future of the age-related macular degeneration market.
Request Free Sample @ https://www.technavio.com/talk-to-us?report=IRTNTR70644
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
View original content to download multimedia:https://www.prnewswire.com/news-releases/age-related-macular-degeneration-market-in-pharmaceutical-industry–technavio-301321411.html